RxDoctor Payments Data

Ibrahim Mansour, MD

Interventional Cardiology · Dekalb, ILNPI 1619076619

Payments from drug & device makers

$1,158in general payments, 2019–2025

Across 86 payments — averaging $13.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$377
  • Novartis$133
  • Pfizer$119
  • Esperion Therapeutics, Inc.$89
  • AstraZeneca$77
  • Amgen$59
  • plus $304 from 12 others

What the payments were for

  • Food & beverage$1,13798%
  • Education$212%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,158 in reported general payments places this provider in the 10th percentile of 303 interventional cardiology providers in Illinois.

See all interventional cardiology providers in Illinois

Medicare billing

Part B allowed, 2024
$22,567
Medicare patients
132
Services billed
244

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Dekalb

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →